Crinetics Pharmaceuticals, Inc.

CRNXNASDAQHealthcare● Active

$32.92

$-1.71(-4.94%)

Market Cap$3.5B

P/E Ratio—

52W High$57.99

52W Low$25.83

Avg Volume1.2M

Open$34.65

Beta0.24

Employees Ownership Insider Trades

Crinetics Pharmaceuticals, Inc. (CRNX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CRNX · as of Feb 26, 2026

Latest filing snapshot

594

+157+35.93%vs prior year

Crinetics Pharmaceuticals, Inc. (CRNX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

594

Change (1Y)

+157

Growth % (1Y)

+35.93%

Revenue / Employee

$13.0K

Net Income / Employee

$-783.4K

Market Cap

$3.5B

CRNX Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	594	+157	+35.93%
2025-02-27	2024-12-31	437	+147	+50.69%
2024-02-28	2023-12-31	290	+80	+38.10%
2023-02-28	2022-12-31	210	+67	+46.85%
2022-03-30	2021-12-31	143	+50	+53.76%
2021-03-30	2020-12-31	93	+25	+36.76%
2020-03-09	2019-12-31	68	+21	+44.68%
2019-03-13	2018-12-31	47	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ACAD

ACADIA Pharmaceuticals Inc.

653$3.7B #2

CRNX

Crinetics Pharmaceuticals, Inc.YOU

Kymera Therapeutics, Inc.

208$6.1B #5

DYN

Dyne Therapeutics, Inc.

192$2.8B #6

AKRO

Akero Therapeutics, Inc.

69$4.5B #7

NAMS

NewAmsterdam Pharma Company N.V.

68$3.7B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CRNX peer comparison

About CRNX employees

CRNX Employees · Headcount

Crinetics Pharmaceuticals, Inc. (CRNX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Crinetics Pharmaceuticals, Inc. had 594 full-time employees globally. Full-time employees only. Global consolidated headcount.

Crinetics Pharmaceuticals, Inc. employs 594 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $12,956, reflecting the company's operational efficiency.

Crinetics Pharmaceuticals, Inc.'s workforce increased by 157 (35.93%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Crinetics Pharmaceuticals, Inc.'s revenue per employee of $12,956 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CRNX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Crinetics Pharmaceuticals, Inc. had 594 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Crinetics Pharmaceuticals, Inc. employee counthow many employees does Crinetics Pharmaceuticals, Inc. haveCRNX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26